Abstract
Systems biology promises to personalize medicine via network-based biomarkers that predict therapeutic effectiveness. Toward this goal, Chang et al. (2009) recently introduced a systems-based approach to break down oncogenic signaling networks into modules that predict the effectiveness of pathway-specific therapeutics.
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Biomarkers, Pharmacological / analysis*
-
Cell Line, Tumor
-
Gene Expression Regulation, Neoplastic*
-
Humans
-
Neoplasms / drug therapy
-
Neoplasms / genetics*
-
Signal Transduction*
-
Systems Biology
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Biomarkers, Pharmacological